Home›Companies›Biotech & Pharma›Phythera Therapeutics

Phythera Therapeutics Inc.

Updated Oct 27, 2026·Latest SEC filing May 16, 2024·Suggest an edit

About Phythera Therapeutics

Phythera Therapeutics is a private company based in Irvine, California, incorporated in 2021 in Delaware. It has reported $468 raised in one offering on Form D since May 2024. Its chief executive is Igor Nasonkin, Ph.D..

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 17, 2023May 16, 2024$468fully sold10$47EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Phythera Therapeutics's Form D filed May 16, 2024.

NT
Ngoc Tran
Executive officer and promoter
ID
Igor Nasonkin, Ph.D.
Chief Executive Officer and director
CD
Charles Irving, Ph.D.
Executive officer, director and promoter
HD
Hal Sternberg, Ph.D.
Executive officer, director and promoter
JS
Judith Segall
Executive officer, director and promoter
ZN

Sources

  1. SECPhythera Therapeutics Inc. filing history